Groupe Hospitalier Saint André

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Brain metastases1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Completed2 trials

Lead sponsor

• Dragonfly Therapeutics1 trial
• Intergroupe Francophone de Cancerologie Thoracique1 trial

Closed trials

• Completed

  Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation

  NCT04233021· Phase 2· Intergroupe Francophone de Cancerologie Thoracique· Source

• Completed

  Study of DF1001 in Patients With Advanced Solid Tumors

  NCT04143711· Phase 1/2· Dragonfly Therapeutics· Source